Browse > Article
http://dx.doi.org/10.6116/kjh.2014.29.4.29.

The inhibitory effect of Orostachys japonicus on dextran sulfate sodium-induced colitis in mice  

Myung, Noh-Yil (Department of Oriental Medicine and Healthcare, Wonkwang Digital University)
Publication Information
The Korea Journal of Herbology / v.29, no.4, 2014 , pp. 29-34 More about this Journal
Abstract
Objectives : Ulcerative colitis (UC) is an inflammatory bowel disease, which is one of chronic gastrointestinal disorders. Orostachys japonicus (OJ) has been used as a traditional medicine for various diseases including gastric cancer, gastric ulcers and intoxication. However, the regulatory effect of OJ on intestinal inflammation has not been fully understood, yet. The aim of this study was to investigate the effect of OJ on dextran sulfate sodium (DSS)-induced colitis in mice. Methods : To ascertain the pharmacological effects of OJ, the colitis mice were induced by drinking water containing 5% DSS for 7 days. Mice were randomized into groups receiving OJ (100 mg/kg), sulfasalazine (150 mg/kg) as a positive control, or water as a negative control. We evaluated the effects of OJ on DSS-induced the clinical signs, measuring weight loss and colon length. In addition, the inhibitory effect of OJ on the tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) level was determined by enzyme-linked immunosorbent assay in colitis tissue. Results : The results indicated that mice treated with DSS showed remarkable clinical signs, including weight loss, and reduced colon length. However, treatment with OJ significantly improved the weight loss and DAI as clinical symptoms. Moreover, OJ reduced the TNF-${\alpha}$ levels in DSS-treated colon tissues. Conclusions : Collectively, the findings of this study provide us with novel insights into the pharmacological actions of OJ as a potential medicine for use in the treatment of ulcerative colitis.
Keywords
Orostachys japonicus; Ulcerative Colitis; Dextran Sulfate Sodium; Tumor necrosis factor-${\alpha}$;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci. 1992 ; 37(6) : 818-26.   DOI   ScienceOn
2 Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998 ; 22(4) : 382-9.   DOI   ScienceOn
3 Medzhitov R, Janeway CA Jr. "Innate immunity: impact on the adaptive immune response". Curr Opin Immunol. 1997 ; 9(1) : 4-9.   DOI   ScienceOn
4 Ogata H, Hibi T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm Des. 2003 ; 9(14) : 1107-13.   DOI   ScienceOn
5 Zheng P, Niu FL, Liu WZ, Shi Y, Lu LG. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats. World J Gastroenterol. 2005 ; 11(31) : 4912-5.   DOI
6 Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H. Paeonol attenuates TNBS-induced colitis by inhibiting NF-B and STAT1 transactivation. Toxicol Appl Pharmacol. 2006 ; 217(1) : 35-42.   DOI   ScienceOn
7 Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. Novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990 ; 98(3) : 694-702.   DOI
8 Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002 ; 15(1) : 79-94.   DOI   ScienceOn
9 Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993 ; 38(9) : 1722-34.   DOI   ScienceOn
10 Domenech E. Inflammatory bowel disease: current therapeutic options. Digestion. 2006 ; 73(1) : 67-76.   DOI   ScienceOn
11 Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000 ; 51 : 289-98.   DOI   ScienceOn
12 Raddatz D, Bockemuhl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol. 2005 ; 17 : 547-57   DOI
13 Ryu DS, Kim SH, Kwon JH, Lee DS. Orostachys japonicus induces apoptosis and cell cycle arrest through the mitochondria-dependent apoptotic pathway in AGS human gastric cancer cells. Int J Oncol. 2014 ; 45(1) : 459-69.   DOI
14 Jung BS, Shin MK. Dictionary of the Medical Plants. Seoul : Younglimsa. 1990 : 600-1.
15 Lee HS, Lee GS, Kim SH, Kim HK, Suk DH, Lee DS. Anti-oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicusin LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway. BMB Rep. 2014 ; 47(2) : 98-103.   DOI   ScienceOn
16 Danese S, Sans M, Fiocchi C. Inflammatory bowel disease; the role of environmental factors. Autoimmun Rev. 2004 ; 3 : 394-400.   DOI   ScienceOn
17 Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002 ; 15 : 79-94.   DOI   ScienceOn
18 Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ. Disease-related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut. 2010 ; 59(2) : 227-35.   DOI   ScienceOn
19 Lichtenstein GR, Rutgeerts P. Inflamm Bowel Dis. 2010 ; 16(2) : 338-46.   DOI   ScienceOn
20 Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004 ; 3(5) : 394-400.   DOI   ScienceOn
21 Bae KH. Illustrated Book of Health for Longevity. Seoul : Kyohaksa. 2003 : 180.
22 Hyams JS. Inflammatory bowel disease. Pediatr Rev. 2000 ; 21 : 291-5.   DOI   ScienceOn